查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1912437

后生元成分市场：按来源、形态、应用和通路划分 - 全球预测（2026-2032年）

Postbiotics Raw Material Market by Source, Form, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，益生元成分市场价值将达到 1.5972 亿美元，到 2026 年将成长至 1.7663 亿美元，到 2032 年将达到 3.0322 亿美元，复合年增长率为 9.59%。

关键市场统计数据
基准年 2025 1.5972亿美元
预计年份：2026年 1.7663亿美元
预测年份 2032 3.0322亿美元
复合年增长率 (%) 9.59%

本文简要概述了后生元成分如何从实验室概念发展成为用途广泛、性能稳定的成分，并推动过程的配方策略。

后生元成分已迅速从学术研究发展成为多个行业配方师和製造商的必备原料。这些成分由灭活的微生物细胞、细胞碎片、代谢物和功能性萃取物组成，与活性益生菌和化学惰性益生元相比，具有独特的生物学和功能性作用。随着科学表征和生产控制的不断完善，后生元因其稳定性、安全性和在复杂配方中的多功能性而日益受到认可。这吸引了那些在不宜或不宜使用活性微生物的情况下寻求可预测性能的配方师的注意。

科学、製造和商业力量如何融合，重塑供应链动态，并重新定位后生元成分在高价值产品类型中的应用

后生元成分的市场格局正在经历变革性变化，科学、生产和商业性因素的共同作用重新定义了机会和风险。在科学层面，对宿主-微生物相互作用和生物活性代谢物谱的更深入机制理解，使得针对特定功能性结果的标靶原料选择成为可能。这促使配方师不再局限于泛泛的健康宣称，而是转向能够明确作用机制的特定应用场景。

评估2025年关税对后生元成分价值链的策略性连锁反应，包括对供应链韧性、采购决策和配方策略的影响

2025年美国关税政策对后生元成分供应链产生了复杂的影响，需要企业进行策略调整，而非单纯转移成本。在供应方面，关税压力迫使配方师和原料采购者重新评估采购区域，并加强供应商选择流程。在关税导致某些进口成分的到岸成本上升的情况下，采购商正努力透过供应商多元化、发展本地製造伙伴关係以及加快技术转移来降低贸易政策波动带来的风险。

可操作的细分讯息，揭示了製剂形式、应用案例和通路如何共同决定技术需求和商业性机会。

详细的市场区隔揭示了技术差异和商业性吸引力最大的领域，这些差异为产品开发和市场推广策略的选择提供了基础。基于成分的市场研究分类包括双歧桿菌、乳酸桿菌、酵母菌和链球菌，每种菌种在人类和动物应用历史、代谢产物谱以及安全性和监管方面均存在差异，从而影响其应用领域。基于剂型的分类涵盖胶囊、液体、粉末和片剂，其中液体进一步细分为水性配方和油性配方，粉末则细分为冻干粉和喷雾干燥粉。这些剂型层面的差异直接影响生产需求、储存特性和给药途径的选择，指南特定应用的筛选。

区域法规环境、生产能力和消费者偏好将如何独特地塑造关键全球市场中后生元成分的商业策略

地理位置对后生元成分的供应链决策、监理应变和市场推广策略有显着影响。美洲地区成熟的营养保健品和机能性食品生产商对后生元成分的需求强劲，他们越来越重视转化科学和线上直销销售管道，强调清晰的产品声明和可追溯性。该地区还拥有大规模的契约製造，能够支持将新成分快速整合到消费品中，并实现配方的快速优化。

深入了解原料生产商的差异化、技术投资和伙伴关係模式，将决定哪些公司将在配方师和商业客户中获得优先地位。

原料领域的竞争因素取决于菌株来源、製程控制、分析严谨性和商业性支援方面的差异。领先的原料供应商正投资于可验证的品质系统、菌株表征和可靠的分析证书，以满足配方开发人员和受监管目标产品类别日益复杂的需求。供应商、契约製造和研究机构之间的策略联盟正成为加速新产品上市和降低规模化生产风险的主要途径。

为製造商和供应商提供切实可行的、优先排序的建议，以增强供应链韧性、加快产品开发并提高跨通路商业性可行性。

行业领导者应采取一系列协同措施，将科学进步和市场趋势转化为可持续的竞争优势。首先，透过对多家地理分散的供应商进行资格认证，并投资于技术转移能力建设，增强供应链合格，从而在商业性可行的情况下实现本地化生产。其次，将研发投资与明确的应用需求相匹配，重点关注菌株特异性表征、配方相容性以及可扩展的加工方法，例如可控灭活和先进干燥技术。

对混合方法研究过程进行透明描述，结合技术检验、相关人员访谈和三角测量技术，以得出可操作且检验的研究结果。

本分析采用定性和定量相结合的研究方法，以确保获得可靠且可操作的洞见。主要研究包括对原料研发人员、契约製造生产商、製剂研发人员和法规专家进行结构化访谈，以了解即时营运限制、证据要求和商业性优先事项。次要研究包括仔细审查科学文献、专利申请和监管指南，检验作用机制声明并绘製智慧财产权格局图。

简洁扼要的总结强调了整合技术检验、供应链韧性和有针对性的商业化对于抓住新机会的策略必要性。

综合来看，这些洞见预示着未来后生元成分不再只是可互换的商品成分，而是能够跨多个品类打造差异化产品策略的关键因素。菌株科学、製程控制和分析检验的进步，使供应商能够提供清晰的功能性价值提案，满足目标产品产品和消费品的需求；同时，不断变化的贸易趋势和分销模式，也使得供应链韧性和监管准备成为企业竞争的重中之重。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 后生元成分市场（依来源划分）

  • 双歧桿菌
  • 乳酸桿菌
  • 酿酒酵母
  • 链球菌

9. 后生元成分市场（依形式划分）

  • 胶囊
  • 液体
    • 水溶液
    • 油腻的
  • 粉末
    • 冷冻干燥
    • 喷雾干燥
  • 药片

第十章 后生元成分市场（依应用领域划分）

  • 动物饲料
  • 化妆品
  • 营养补充品
  • 机能性食品
  • 製药

第十一章 后生元成分市场（依通路划分）

  • 直销
  • 批发商
  • 电子商务
  • 零售药房

第十二章：各地区的后生元成分市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 后生元成分市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国后生元成分市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国后生元成分市场

第十六章 中国后生元原料市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Archer Daniels Midland Company
  • BioGaia AB
  • Cargill, Incorporated
  • Chr. Hansen Holding A/S
  • Gnosis by Lesaffre SA
  • International Flavors & Fragrances Inc.
  • Kerry Group plc
  • Lallemand Inc.
  • Lesaffre SA
  • MCLS Europe BV
  • Morinaga Milk Industry Co., Ltd.
  • Novozymes A/S
  • Postbiotica Srl
  • Probiotical SpA
  • Sabinsa Corporation
Product Code: MRR-AE420CB139A1

The Postbiotics Raw Material Market was valued at USD 159.72 million in 2025 and is projected to grow to USD 176.63 million in 2026, with a CAGR of 9.59%, reaching USD 303.22 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 159.72 million
Estimated Year [2026] USD 176.63 million
Forecast Year [2032] USD 303.22 million
CAGR (%) 9.59%

Concise strategic overview of how postbiotic raw materials have evolved from laboratory concepts to versatile, stable ingredients driving cross-sector formulation strategies

Postbiotic raw materials have moved quickly from academic curiosity to essential inputs for formulators and manufacturers across multiple industries. These materials, consisting of inactivated microbial cells, cell fragments, metabolites, and functional extracts, deliver biological and functional benefits distinct from living probiotics and chemically inert prebiotics. As scientific characterization and manufacturing control improve, postbiotics are becoming valued for their stability, safety profile, and versatility in complex formulations. This has attracted attention from formulators seeking predictable performance where the use of live microorganisms is impractical or undesirable.

The contemporary landscape for these ingredients reflects deeper collaboration between microbiologists, process engineers, and regulatory scientists. Advances in strain selection, controlled inactivation techniques, and analytical methods for potency and purity have reduced technical barriers and enhanced reproducibility. At the same time, cross-sector interest-spanning dietary supplements, functional foods, cosmetics, pharmaceuticals, and animal feed-has broadened the set of performance attributes that developers prioritize, including immunomodulation, barrier support, and formulation compatibility. Together, these dynamics underscore why postbiotic raw materials warrant strategic attention from product developers and supply chain managers.

How converging scientific, manufacturing, and commercial forces are reshaping supply dynamics and repositioning postbiotic raw materials across high-value product categories

The postbiotic raw material landscape is experiencing transformative shifts driven by scientific, manufacturing, and commercial forces that collectively redefine opportunity and risk. At the scientific level, more rigorous mechanistic understanding of host-microbe interactions and of bioactive metabolite profiles has enabled selection of targeted materials for specific functional outcomes. This has prompted formulators to move beyond general wellness claims and toward targeted use cases where defined modes of action can be substantiated.

Manufacturing transformations are equally consequential: refinements in inactivation processes, improved downstream purification, and scalable drying methods have increased availability of technical-grade materials suitable for high-value applications. Commercially, shifts in consumer expectations and distribution dynamics are favoring stable, easy-to-dose ingredients that integrate cleanly into capsules, tablets, powders, liquids, and topical systems. These converging developments have sharpened competitive differentiation around strain lineage, process traceability, and analytical certification, elevating the importance of transparent sourcing and robust quality documentation.

Assessing the strategic ripple effects of 2025 tariff measures on supply resilience, sourcing decisions, and formulation strategies across the postbiotic ingredient value chain

United States tariff actions in 2025 have produced a complex set of consequences for the postbiotic raw material supply chain that require strategic adaptation rather than simple cost pass-through. On the supply side, tariff pressure has incentivized formulators and ingredient buyers to re-evaluate sourcing geographies and to intensify supplier qualification efforts. Where tariffs raise landed costs on specific imported components, purchasers have pursued supplier diversification, sought local manufacturing partnerships, and accelerated technical transfers to mitigate exposure to trade policy volatility.

Downstream implications have emerged across procurement planning, inventory strategies, and formulation choices. Some manufacturers have reformulated to favor ingredients that are more readily sourced within lower-tariff jurisdictions or that can be produced at scale domestically under existing regulatory frameworks. Distributors and channel partners have adjusted margin expectations and contractual terms to accommodate increased logistics complexity. At the same time, tariff-driven uncertainty has highlighted strategic vulnerabilities in single-source dependencies and has amplified the value of supplier transparency, backward traceability, and flexibility in lead times. In aggregate, the effect of tariff measures has been to accelerate structural changes in sourcing and to prioritize supply chain resilience as a core component of competitive strategy.

Actionable segmentation intelligence revealing how source selection, formulation format, application use case, and distribution pathway jointly determine technical needs and commercial opportunity

Detailed segmentation reveals where technical differentiation and commercial traction are most pronounced, and these distinctions inform product development and go-to-market choices. Based on Source, market study categorization includes Bifidobacterium, Lactobacillus, Saccharomyces, and Streptococcus, each presenting distinct histories of human and animal use, differing metabolite profiles, and unique safety and regulatory footprints that influence where they are preferred. Based on Form, the segmentation spans Capsule, Liquid, Powder, and Tablet formats, with Liquid further defined into Aqueous and Oil Based presentations and Powder further classified as Freeze Dried and Spray Dried; these form-level differences translate directly into manufacturing requirements, storage profiles, and route-of-administration considerations that inform selection for a given application.

Based on Application, the examined categories include Animal Feed, Cosmetics, Dietary Supplements, Functional Foods, and Pharmaceuticals, a distribution that reflects both established and emerging routes to market and sets diverse performance expectations for potency, purity, and regulatory substantiation. Based on Distribution Channel, the study looks across Direct Sales, Distributors, E Commerce, and Retail Pharmacy, highlighting how channel economics, regulatory oversight, and consumer purchase behavior shape packaging, product claims, and commercial support models. Recognizing how each dimension intersects with formulation science and regulatory constraints allows stakeholders to prioritize investments in R&D, quality systems, and channel-specific launch plans.

How regional regulatory environments, manufacturing capacity, and consumer preferences uniquely shape commercial strategies for postbiotic materials across major global markets

Geographic dynamics materially influence supply chain decisions, regulatory engagement, and route-to-market strategies for postbiotic raw materials. In the Americas, there is strong demand from established dietary supplement and functional food manufacturers, with a growing emphasis on translational science and on-line direct-to-consumer channels that reward clear claims and traceability. This region also contains substantial contract manufacturing capacity, which supports faster integration of new raw materials into consumer-facing products and enables rapid iteration of dosage forms.

In Europe, Middle East & Africa, regulatory rigor and diverse national frameworks require precise documentation and careful labeling strategies, while consumer interest in natural and clinically supported ingredients remains robust. The region's sophisticated cosmetics and pharmaceutical sectors create opportunities for specialized, highly characterized postbiotic ingredients. In Asia-Pacific, a combination of strong manufacturing ecosystems, active ingredient innovation, and rapidly evolving retail channels drives both scale manufacturing and novel application development. Across all regions, local regulatory expectations, intellectual property considerations, and logistics constraints inform where to locate production, how to structure partnerships, and what evidence base will best support commercialization.

Insights into supplier differentiation, technology investment, and partnership models that determine which companies secure preferred status with formulators and commercial customers

Competitive dynamics in the raw material segment are defined by differentiation in strain provenance, process control, analytical rigour, and commercial support. Leading ingredient providers are investing in demonstrable quality systems, strain characterization, and robust certificates of analysis to meet the increasingly exacting needs of formulators and regulated product categories. Strategic partnerships between suppliers, contract manufacturers, and research institutions are becoming a primary route to accelerate new product introductions and to de-risk scale-up challenges.

At the commercial level, firms that combine formulation support, flexible packaging, and reliable logistics are establishing preferred supplier status with brand owners. Investment in pilot-scale production, expanded drying capacities such as freeze-drying and spray-drying, and validated inactivation processes yield operational advantages during product launches. Additionally, companies that prioritize transparent supply chains, third-party testing, and regulatory engagement are better positioned to address both customer procurement demands and evolving compliance expectations in multiple end-use markets.

Practical and prioritized recommendations for manufacturers and suppliers to build supply resilience, accelerate product development, and strengthen commercial execution across channels

Industry leaders should pursue a set of coordinated actions to translate scientific progress and market signals into durable competitive advantage. First, strengthen supply chain resilience by qualifying multiple suppliers across geographies and by investing in technical transfer capabilities to enable local production where commercially warranted. Second, align R&D investments with defined application needs, focusing on strain-specific characterization, formulation compatibility, and scalable processing methods such as controlled inactivation and advanced drying techniques.

Third, deepen commercial support offerings through co-development, technical documentation packages, and channel-specific materials for direct sales, distributors, e-commerce platforms, and retail pharmacy partners. Fourth, engage proactively with regulatory bodies to clarify permissible claims and to expedite necessary registrations or notifications; robust regulatory engagement reduces time-to-market risk. Finally, embed sustainability and traceability practices into sourcing and manufacturing narratives to meet growing buyer and end-consumer expectations for provenance and environmental responsibility. Taken together, these actions will help companies convert technical capability into reliable market differentiation.

Transparent description of a mixed-methods research process combining technical validation, stakeholder interviews, and triangulation to produce actionable and verifiable insights

The research approach underpinning this analysis combined qualitative and quantitative qualitative techniques to ensure robust, actionable findings. Primary research included structured interviews with ingredient developers, contract manufacturers, formulators, and regulatory experts to capture real-time operational constraints, evidence needs, and commercial priorities. Secondary exploration of scientific literature, patent filings, and regulatory guidelines was used to validate mechanistic claims and to map intellectual property landscapes.

Analytical triangulation integrated laboratory method reviews, manufacturing process assessments, and supply chain mapping to surface where technical bottlenecks and sourcing risks exist. Validation steps included cross-checks with independent technical advisers and with procurement professionals to ensure that recommended actions are both technically feasible and commercially viable. This blend of technical validation, stakeholder interviews, and triangulated evidence provides a balanced foundation for the insights and recommendations presented here.

Concise concluding synthesis highlighting the strategic imperatives for integrating technical validation, supply resilience, and targeted commercialization to capture emerging opportunities

The collective evidence points to a future where postbiotic raw materials become differentiated components of multi-category product strategies rather than interchangeable commodity inputs. Advances in strain science, process control, and analytical verification are enabling suppliers to present clear functional value propositions that meet the needs of regulated and consumer-facing applications alike. Meanwhile, changing trade dynamics and distribution patterns are elevating supply chain resilience and regulatory preparedness as competitive priorities.

For stakeholders across the value chain, the imperative is clear: integrate technical certification and supply transparency into commercial narratives, diversify sourcing to mitigate trade and logistics risk, and invest in targeted R&D that maps directly to application-specific performance criteria. Organizations that adopt these priorities will be better positioned to capitalize on the growing demand for stable, well-characterized bioactive ingredients while minimizing exposure to policy and market disruptions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Postbiotics Raw Material Market, by Source

  • 8.1. Bifidobacterium
  • 8.2. Lactobacillus
  • 8.3. Saccharomyces
  • 8.4. Streptococcus

9. Postbiotics Raw Material Market, by Form

  • 9.1. Capsule
  • 9.2. Liquid
    • 9.2.1. Aqueous
    • 9.2.2. Oil Based
  • 9.3. Powder
    • 9.3.1. Freeze Dried
    • 9.3.2. Spray Dried
  • 9.4. Tablet

10. Postbiotics Raw Material Market, by Application

  • 10.1. Animal Feed
  • 10.2. Cosmetics
  • 10.3. Dietary Supplements
  • 10.4. Functional Foods
  • 10.5. Pharmaceuticals

11. Postbiotics Raw Material Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. E Commerce
  • 11.4. Retail Pharmacy

12. Postbiotics Raw Material Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Postbiotics Raw Material Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Postbiotics Raw Material Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Postbiotics Raw Material Market

16. China Postbiotics Raw Material Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Archer Daniels Midland Company
  • 17.6. BioGaia AB
  • 17.7. Cargill, Incorporated
  • 17.8. Chr. Hansen Holding A/S
  • 17.9. Gnosis by Lesaffre S.A.
  • 17.10. International Flavors & Fragrances Inc.
  • 17.11. Kerry Group plc
  • 17.12. Lallemand Inc.
  • 17.13. Lesaffre S.A.
  • 17.14. MCLS Europe B.V.
  • 17.15. Morinaga Milk Industry Co., Ltd.
  • 17.16. Novozymes A/S
  • 17.17. Postbiotica S.r.l.
  • 17.18. Probiotical S.p.A.
  • 17.19. Sabinsa Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POSTBIOTICS RAW MATERIAL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SACCHAROMYCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SACCHAROMYCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SACCHAROMYCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY STREPTOCOCCUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY STREPTOCOCCUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY STREPTOCOCCUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY AQUEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY AQUEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY AQUEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY OIL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY OIL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY OIL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FREEZE DRIED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FREEZE DRIED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FREEZE DRIED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SPRAY DRIED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SPRAY DRIED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SPRAY DRIED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FUNCTIONAL FOODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FUNCTIONAL FOODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. GCC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 139. GCC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 140. GCC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 141. GCC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 160. G7 POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 161. G7 POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. NATO POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 168. NATO POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL POSTBIOTICS RAW MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA POSTBIOTICS RAW MATERIAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)